SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday.

Shares of Science Applications International Corporation SAIC fell sharply in today's pre-market trading after the company reported first-quarter results.

Science Applications Intl posted adjusted earnings of $1.92 per share, missing market estimates of $2.22 per share. The company posted quarterly sales of $1.88 billion versus expectations of $1.87 billion.

SAIC shares dipped 6.5% to $108.00 in the pre-market trading session.

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

Here are some other stocks moving lower in pre-market trading.

SharpLink Gaming, Inc. SBET declined 18.4% to $62.60 in pre-market trading after the company filed for mixed shelf offering.
ContextLogic Inc. LOGC shares tumbled 18.3% to $6.70 in pre-market trading. ContextLogic will commence trading on the OTC Markets and delist from the Nasdaq.
Lucid Diagnostics Inc. LUCD shares fell 15.1% to $1.18 in pre-market trading. Lucid Diagnostics may offer sell shares of common stock of up to $25 million.
Algoma Steel Group Inc. ASTL fell 9.2% to $4.78 in pre-market trading.
LiveWire Group, Inc. LVWR dipped 8.7% to $4.10 in pre-market trading.
Definitive Healthcare Corp. DH fell 7.3% to $3.07 in pre-market trading.
Arvinas, Inc. ARVN fell 6.9% to $6.70 in pre-market trading. Arvinas and Pfizer’s Vepdegestrant demonstrated statistically significant 2.9-month PFS benefit over Fulvestrant in ESR1-mutant second-line advanced breast cancer.
Qudian Inc. QD fell 6.4% to $2.77 in pre-market trading. Qudian reported first quarter unaudited financial results on Friday.
IperionX Limited IPX fell 5.5% to $22.86 in pre-market trading.
Tesla, Inc. TSLA fell 1.5% to $341.25 in pre-market trading. Tesla experienced a decline in sales in China compared to rivals like Nio Inc. NIO, Xpeng Inc. XPEV, Li Auto Inc. LI and BYD Co. Ltd. BYDDY BYDDF, which posted strong growth in May.